173
Participants
Start Date
August 31, 2000
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
somatropin
Novo Nordisk Investigational Site, New York
Novo Nordisk Investigational Site, The Bronx
Novo Nordisk Investigational Site, New Hyde Park
Novo Nordisk Investigational Site, Brooklyn
Novo Nordisk Investigational Site, Stony Brook
Novo Nordisk Investigational Site, Buffalo
Novo Nordisk Investigational Site, Hershey
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Columbia
Novo Nordisk Investigational Site, Charleston
Novo Nordisk Investigational Site, Tallahassee
Novo Nordisk Investigational Site, Gainesville
Novo Nordisk Investigational Site, St. Petersburg
Novo Nordisk Investigational Site, Memphis
Novo Nordisk Investigational Site, Columbus
Novo Nordisk Investigational Site, Cleveland
Novo Nordisk Investigational Site, Cleveland
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Indianapolis
Novo Nordisk Investigational Site, Kalamazoo
Novo Nordisk Investigational Site, Iowa City
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Skokie
Novo Nordisk Investigational Site, Kansas City
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, San Diego
Novo Nordisk Investigational Site, Sacramento
Novo Nordisk Investigational Site, Portland
Novo Nordisk Investigational Site, Seattle
Novo Nordisk Investigational Site, Stanford
Novo Nordisk Investigational Site, New Haven
Novo Nordisk Investigational Site, Shreveport
Novo Nordisk Investigational Site, Springfield
Novo Nordisk Investigational Site, Worcester
Novo Nordisk Investigational Site, Morristown
Novo Nordisk Investigational Site, Milwaukee
Lead Sponsor
Novo Nordisk A/S
INDUSTRY